MCID: PRD008
MIFTS: 46

Periodontitis

Categories: Oral diseases, Genetic diseases, Blood diseases, Rare diseases

Aliases & Classifications for Periodontitis

MalaCards integrated aliases for Periodontitis:

Name: Periodontitis 12 29 42 14 69
Chronic Pericementitis 12
Chronic Periodontitis 69

Classifications:



External Ids:

Disease Ontology 12 DOID:824
ICD10 33 K05.3
MeSH 42 D010518
NCIt 47 C34918
UMLS 69 C0031099

Summaries for Periodontitis

MalaCards based summary : Periodontitis, also known as chronic pericementitis, is related to aggressive periodontitis and periodontal disease, and has symptoms including halitosis, snoring and tenderness of gums. An important gene associated with Periodontitis is CTSC (Cathepsin C). The drugs Amoxicillin and Metronidazole have been mentioned in the context of this disorder. Affiliated tissues include bone, neutrophil and endothelial.

Wikipedia : 72 Periodontitis, also known as gum disease and pyorrhea, is a set of inflammatory diseases affecting the... more...

Related Diseases for Periodontitis

Diseases in the Periodontitis family:

Periodontitis 1, Juvenile Susceptibility to Localized Juvenile Periodontitis

Diseases related to Periodontitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 288)
id Related Disease Score Top Affiliating Genes
1 aggressive periodontitis 12.4
2 periodontal disease 12.3
3 periapical periodontitis 12.3
4 periodontitis 1, juvenile 12.2
5 ehlers-danlos syndrome, periodontal type, 1 12.1
6 ehlers-danlos syndrome, periodontal type, 2 12.1
7 chronic apical periodontitis 12.0
8 acute apical periodontitis 12.0
9 periodontal ehlers-danlos syndrome 11.9
10 hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome 11.8
11 suppurative periapical periodontitis 11.8
12 periodontitis, aggressive, 2 11.7
13 susceptibility to localized juvenile periodontitis 11.7
14 papillon-lefevre syndrome 11.6
15 gingivitis 11.5
16 periodontosis 11.4
17 necrotizing ulcerative gingivitis 11.3
18 acute pericementitis 11.2
19 haim-munk syndrome 11.0
20 hajdu-cheney syndrome 11.0
21 ligneous conjunctivitis 11.0
22 tooth ankylosis 10.9
23 aplasia of lacrimal and salivary glands 10.8
24 dental abscess 10.8
25 singleton-merten syndrome 1 10.7
26 amelogenesis imperfecta, type iiia 10.7
27 leukocyte adhesion deficiency, type iii 10.7
28 otodental dysplasia 10.7
29 alopecia, epilepsy, pyorrhea, mental subnormality 10.7
30 arthritis 10.2
31 rheumatoid arthritis 10.2
32 gingival overgrowth 10.1
33 obesity 10.1
34 atherosclerosis 10.1
35 dental caries 10.1
36 gingival recession 10.1
37 endotheliitis 10.1
38 heart disease 10.0
39 root resorption 10.0
40 kidney disease 10.0
41 osteoporosis 10.0
42 artery disease 9.9
43 coronary artery disease 9.9
44 root caries 9.9
45 hypoxia 9.9
46 pulpitis 9.9
47 fibromatosis 9.9
48 neutropenia 9.9
49 mucositis 9.9
50 lichen planus 9.9

Comorbidity relations with Periodontitis via Phenotypic Disease Network (PDN):


Acute Cystitis Dental Caries
Heart Disease

Graphical network of the top 20 diseases related to Periodontitis:



Diseases related to Periodontitis

Symptoms & Phenotypes for Periodontitis

UMLS symptoms related to Periodontitis:


halitosis, snoring, tenderness of gums, leukorrhea, purulent discharge

Drugs & Therapeutics for Periodontitis

Drugs for Periodontitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 365)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3 26787-78-0 33613 2171
2
Metronidazole Approved Phase 4,Phase 2,Phase 3,Phase 1 443-48-1 4173
3 sodium fluoride Approved Phase 4,Phase 3 7681-49-4
4
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 51-43-4 5816
5 Racepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1
6
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 55-56-1 9552079 2713
7
Hexetidine Approved Phase 4 141-94-6
8
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2 22916-47-8 4189
9
Ciprofloxacin Approved, Investigational Phase 4,Phase 1 85721-33-1 2764
10
Azithromycin Approved Phase 4,Phase 2 83905-01-5 55185 53477736 447043
11
Menthol Approved Phase 4,Early Phase 1 2216-51-5 16666
12
Ethanol Approved Phase 4,Phase 3 64-17-5 702
13
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
14
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
15
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
16
Norgestimate Approved Phase 4 35189-28-7 6540478
17
Montelukast Approved Phase 4 158966-92-8 5281040
18
Minocycline Approved, Investigational Phase 4,Phase 3,Phase 1 10118-90-8 5281021
19
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
20
Albendazole Approved, Vet_approved Phase 4 54965-21-8 2082
21
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 564-25-0 54671203
22
Alendronate Approved Phase 4,Phase 2,Phase 3 121268-17-5, 66376-36-1 2088
23
Zoledronic acid Approved Phase 4 118072-93-8 68740
24
Clarithromycin Approved Phase 4,Phase 2,Phase 3 81103-11-9 84029
25
Povidone Approved Phase 4 9003-39-8
26 Povidone-iodine Approved Phase 4 25655-41-8
27
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3 50-78-2 2244
28
Triclosan Approved Phase 4,Phase 3 3380-34-5 5564
29
Coal tar Approved Phase 4,Phase 3 8007-45-2
30
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1,Phase 2 9004-61-9 53477741 24759
31
Ibuprofen Approved Phase 4,Phase 2,Phase 3 15687-27-1 3672
32
Methyltestosterone Approved Phase 4 58-18-4 6010
33
Testosterone Approved, Investigational Phase 4 58-22-0 6013
34
Hydrogen peroxide Approved, Vet_approved Phase 4 7722-84-1 784
35
Lycopene Approved, Nutraceutical Phase 4,Phase 1,Phase 2 502-65-8 446925
36
Lactitol Investigational Phase 4 585-86-4 3871
37
Iodine Investigational Phase 4 7553-56-2 807
38 Anesthetics Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
39 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
40 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
41 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
42 Antiparasitic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
43 Antiprotozoal Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
44 Listerine Phase 4,Phase 3
45 Pharmaceutical Solutions Phase 4,Phase 2,Phase 3,Phase 1
46 Epinephryl borate Phase 4,Phase 3,Phase 2,Phase 1
47 Photosensitizing Agents Phase 4,Phase 2,Phase 3
48 Antifungal Agents Phase 4,Phase 2
49 Anti-Infective Agents, Local Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
50 Cariostatic Agents Phase 4,Phase 3

Interventional clinical trials:

(show top 50) (show all 565)

id Name Status NCT ID Phase Drugs
1 Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis Unknown status NCT02135952 Phase 4 MTZ+AMX
2 Clinical and Microbiological Effects of an Essential Oils Solution Used as an Adjunct to Daily Oral Hygiene Practices in Chronic Periodontitis Patients in Supportive Care Unknown status NCT01195493 Phase 4
3 SRP in Combination With PERIOWAVE in Comparison to SRP Alone in Chronic Periodontitis Unknown status NCT00296881 Phase 4
4 Study of Scaling and Root Planing With PerioWave Versus Scaling and Root Planing Alone in Chronic Periodontitis Unknown status NCT00297531 Phase 4
5 Clinical, Microbiological and Biochemical Effects of the Antimicrobial Photodynamic Therapy Unknown status NCT01532674 Phase 4
6 Role of Stress Reduction Protocol on Outcome of Periodontal Therapy Unknown status NCT02487862 Phase 4
7 Methodology Antiseptic Application, Influence on Oral Biofilm. Unknown status NCT02267239 Phase 4 essential oils, immersion;Chlorhexidine, immersion;essential oils, mouthwash;chlorhexidine, mouthwash
8 Effect of Actonel on Periodontal Health of Postmenopausal Women Unknown status NCT00594334 Phase 4 Risedronate
9 Periodontal Therapy in Coronary Artery Patients Unknown status NCT01609725 Phase 4
10 The Treatment of Periodontal Diseases Unknown status NCT01318928 Phase 4 Metronidazol
11 Omega-3 Fatty Acids in Chronic Periodontitis. Completed NCT01997853 Phase 4 Omega 3 fatty acid;Placebo
12 Adjunctive Photodynamic Therapy in Treatment of Chronic Periodontitis Completed NCT01034501 Phase 4
13 Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole on Patients With Chronic Periodontitis Completed NCT00805558 Phase 4 moxifloxacin;Ciprofloxacin plus metronidazole
14 Study to Evaluate Clinical Efficacy and Safety of Bio Mineral Toothpaste in Patients With Mild Periodontitis Completed NCT01548469 Phase 4
15 Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis Completed NCT02125812 Phase 4
16 Role of Leukotriene Receptor Antagonists in Treatment of Chronic Periodontitis Completed NCT02014532 Phase 4 Montelukast;Placebo
17 Study of Scaling and Root Planing (SRP) With PerioWave vs. SRP Alone in Chronic Periodontitis Completed NCT00297518 Phase 4
18 Adjunctive Antimicrobial Therapy of Periodontitis: Long-Term Effects on Disease Progression and Oral Microbiological Colonization Completed NCT00707369 Phase 4 Amoxicillin and Metronidazole;Placebo
19 Effect of Scaling and Root Planing Along With Topical Application of Commercially Available Curcuma Longa Gel on Superoxide Dismutase and Malondialdehyde Levels in Saliva of Chronic Periodontitis Patients Completed NCT02442453 Phase 4 Topical application of curenext gel;Placebo
20 Role of Herbal Immunomodulators in the Treatment of Chronic Periodontitis Completed NCT01997814 Phase 4 herbal immunomodulator;Placebo
21 Evaluation of Efficacy of Full-mouth Disinfection in Generalized Aggressive Periodontitis Patients Completed NCT02466646 Phase 4 Klorhex® Gel, rinse and sprey
22 The Response of Pathogens to the Respective or Combined Treatment of SRP and Local Minocycline in Chronic Periodontitis Completed NCT02355977 Phase 4 minocycline
23 Propolis Improves Glycemic Control in Subjects With Type 2 Diabetes and Chronic Periodontitis Completed NCT02794506 Phase 4 Propolis;Placebo
24 Treatment of Chronic Periodontitis With Repeated Adjunctive Antimicrobial Photodynamic Therapy Completed NCT02734784 Phase 4
25 Locally Delivered Aloe Vera Gel in the Treatment of Chronic Periodontitis Patients With Diabetes Mellitus Completed NCT02437747 Phase 4 SRP + Aloe
26 Treatment of Aggressive Periodontitis With Repeated Adjunctive Antimicrobial Photodynamic Therapy Completed NCT02049008 Phase 4
27 Effects of the Variation in the Time of Systemic Administration of Metronidazole and Amoxicillin Associated to the Non-surgical Therapy of Chronic Periodontitis. Completed NCT01211223 Phase 4 Administration of Metronidazole plus Amoxicillin
28 Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis Completed NCT02402296 Phase 4 β-1,3/1,6-D-glucan
29 Moxifloxacin in Situ Gel to Treat Periodontal Pocket. Completed NCT02016157 Phase 4 Moxifloxacin
30 Treatment of Periodontitis by Conventional 4 Weekly Sections or Within 24 Hours Completed NCT02215460 Phase 4 FMS chlorhexidine rinse;FMS placebo rinse;FMS azithromycin tablets;FMS placebo tablets;QS azithromycin tablets;QS placebo tablets;QS chlorhexidine rinse;QS placebo rinse
31 "Effect of Scaling and Root Planing on Liver Function Test (Alanine Aminotransferase and Aspartate Aminotransferase) in Systemically Healthy - Chronic Periodontitis Subjects: a Clinical Trial." Completed NCT02583841 Phase 4
32 Long-term Safety of Minocycline in Patients With Gum Disease Completed NCT00668746 Phase 4 Minocycline HCl microspheres
33 Evaluation of the Efficacy of Hyaluronic Acid Gel 0.8% Completed NCT03311906 Phase 4 0.8% Hyaluronic Acid
34 Effect on Teeth and Gum Cleaning in Patients With Gum and Kidney Disease Completed NCT02901743 Phase 4
35 Alternative Antibiotic Regime in the Treatment of GAgP Completed NCT02223702 Phase 4 Amoxicillin;Metronidazole;Moxifloxacin
36 The Use of Erythritol Powder and Metronidazole Gel for the Non-surgical Treatment of Periodontitis Completed NCT02023840 Phase 4 metronidazole gel;placebo
37 EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED Completed NCT02149758 Phase 4 Etoricoxib
38 MTZ Plus AMX in the Treatment of Smokers and Non-smokers Completed NCT01837199 Phase 4 Metronidazole plus Amoxicillin
39 Effect of Arthrospira Platensis (Spirulina) as an Adjunct to Scaling and Root Planing on Salivary Antioxidant Levels in Chronic Periodontitis Subjects Completed NCT02886676 Phase 4 Spirulina capsules
40 A Clinical Trial to Study the Effect of Lycopene in Patients With Gum Disease and type2 Diabetes Mellitus Completed NCT02263352 Phase 4 Lycored soft gels Jagsonpal Pharma, Systemic 8mgms/day
41 Impact of Periodontal Treatment on Serum Levels of Hepcidin and Hemoglobin Completed NCT02641210 Phase 4 Albendazole
42 Locally Delivered Doxycycline Adjunct to Nonsurgical Periodontal Therapy. Completed NCT02487186 Phase 4 Doxicicline
43 Sodium Alendronate in Non Surgical Periodontal Therapy Completed NCT02470611 Phase 4 Sodium alendronate
44 Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis Completed NCT02808988 Phase 4
45 Clarithromycin is an Adjunct to Scaling and Root Planing Completed NCT02359721 Phase 4 tablet clarithromycin 500 mg (Clarino-500) orally
46 Full-mouth and Partial-mouth Scaling and Root Planing in Type 2 Diabetic Subjects Completed NCT02062047 Phase 4 Chlorhexidine
47 Atorvastatin as an Adjunct to DFDBA in Intrabony Defects Completed NCT03009097 Phase 4 DFDBA with atorvastatin
48 Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft Completed NCT02218515 Phase 4
49 Local Minocycline to Reduce Future Inflammation and Bone Loss in Periodontal Maintenance Patients Completed NCT01647282 Phase 4 locally-applied minocycline HCl (1 mg)
50 Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing Completed NCT02197260 Phase 4 3/d 500 mg metronidazole plus 375 mg amoxicillin for 7 days

Search NIH Clinical Center for Periodontitis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: periodontitis

Genetic Tests for Periodontitis

Genetic tests related to Periodontitis:

id Genetic test Affiliating Genes
1 Periodontitis 29

Anatomical Context for Periodontitis

MalaCards organs/tissues related to Periodontitis:

39
Bone, Neutrophil, Endothelial, Heart, Kidney, Testes, Monocytes

Publications for Periodontitis

Articles related to Periodontitis:

(show top 50) (show all 4098)
id Title Authors Year
1
Is there an association between IFN-I^ +874A/T polymorphism and periodontitis susceptibility?: A meta-analysis. ( 28640144 )
2017
2
Influence of obesity on experimental periodontitis in rats: histopathological, histometric and immunohistochemical study. ( 28929308 )
2017
3
Periodontal ligament fibroblasts as a cell model to study osteogenesis and osteoclastogenesis in fibrodysplasia ossificans progressiva. ( 28705683 )
2017
4
Combined antioxidant effects of Neem extract, bacteria, red blood cells and Lysozyme: possible relation to periodontal disease. ( 28797303 )
2017
5
Association between periodontal disease and mortality in people with CKD: a meta-analysis of cohort studies. ( 28814274 )
2017
6
Association Between Asthma and Periodontal Disease: A Systematic Review and Meta-Analysis. ( 28871892 )
2017
7
Intra-abdominal abscesses by Lactococcus lactis ssp cremoris in an immunocompetent adult with severe periodontitis and pernicious anemia. ( 28050349 )
2017
8
Estimation of Antioxidant Levels in Saliva and Serum of Chronic Periodontitis Patients with and without Ischemic Heart Disease. ( 28781595 )
2017
9
Rheumatoid arthritis: New model linking periodontitis and RA. ( 28053334 )
2017
10
Functional Haplotypes in Interleukin 4 Gene Associated with Periodontitis. ( 28114408 )
2017
11
A Clinical Validation of Self-Reported Periodontitis Among Participants in the Black Women's Health Study. ( 28088874 )
2017
12
Increased Root Canal Endotoxin Levels are Associated with Chronic Apical Periodontitis, Increased Oxidative and Nitrosative Stress, Major Depression, Severity of Depression, and a Lowered Quality of Life. ( 28455694 )
2017
13
Adjunctive antimicrobial chemotherapy based on hydrogen peroxide photolysis for non-surgical treatment of moderate to severe periodontitis: a randomized controlled trial. ( 28947757 )
2017
14
Clarithromycin as an Adjunct to One-Stage Full Mouth Ultrasonic Periodontal Debridement in Generalized Aggressive Periodontitis: a Randomized Controlled Clinical Trial. ( 28671507 )
2017
15
Association between the interleukin-1I^ C-511T polymorphism and periodontitis: a meta-analysis in the Chinese population. ( 28252166 )
2017
16
Transplantation of periodontal ligament cell sheets expressing human I^a89defensina893 promotes antia89inflammation in a canine model of periodontitis. ( 28944821 )
2017
17
Periodontal disease and risk of non-Hodgkin lymphoma in the Health Professionals Follow-Up Study. ( 27861844 )
2017
18
The role of leptin as a biomarker in the relationship between periodontitis and chronic migraine. ( 28922461 )
2017
19
Effects of Local Administration of Tiludronic Acid on Experimental Periodontitis in Diabetic Rats. ( 28914593 )
2017
20
Allergic contact stomatitis caused by camphorquinone in a light cure periodontal dressing. ( 28872204 )
2017
21
Transgelin mediates transforming growth factor-I^1-induced proliferation of human periodontal ligament cells. ( 28590058 )
2017
22
Meloxicam medication reduces orthodontically induced dental root resorption and tooth movement velocity: a combined in vivo and in vitro study of dental-periodontal cells and tissue. ( 28044198 )
2017
23
Genetic susceptibility and periodontal disease: a retrospective study on a large italian sample. ( 28757932 )
2017
24
Long-term treatment costs for aggressive periodontitis in a German population. ( 28905412 )
2017
25
Insulin-like growth factor 1 (IGF1) affects proliferation and differentiation and wound healing processes in an inflammatory environment with p38 controlling early osteoblast differentiation in periodontal ligament cells. ( 27769028 )
2017
26
Qualitative and Quantitative Proteome Analysis of Oral Fluids in Health and Periodontal Disease by Mass Spectrometry. ( 27924587 )
2017
27
Local and Plasma Biomarker Profiles in Localized Aggressive Periodontitis. ( 28879248 )
2017
28
Periodontal Disease and Incident Cancer Risk among Postmenopausal Women: Results from the Women's Health Initiative Observational Cohort. ( 28765338 )
2017
29
Idiopathic male infertility related to periodontal and caries status. ( 28746727 )
2017
30
Biomarker levels in gingival crevicular fluid of generalized aggressive periodontitis patients after non-surgical periodontal treatment. ( 28918557 )
2017
31
Autologous Platelet Rich Fibrin in the Treatment of 3-Wall Intrabony Defects in Aggressive Periodontitis - A Randomized Controlled Clinical Trial. ( 28820320 )
2017
32
Prevalence and risk indicators of peri-implantitis in Korean patients with a history of periodontal disease: a cross-sectional study. ( 28861288 )
2017
33
Comparing the efficiency of Er,Cr:YSGG laser and diode laser on human I^-defensin-1 and IL-1I^ levels during the treatment of generalized aggressive periodontitis and chronic periodontitis. ( 28557642 )
2017
34
Cytokine profile in gingival crevicular fluid and plasma of patients with aggressive periodontitis. ( 28868949 )
2017
35
Treatment compliance in patients with aggressive periodontitis - a retrospective case-control study. ( 27899029 )
2017
36
Quantitative Parameters of Interdental Gingiva in Chronic Periodontitis Patients with IFN-I^ Gene Polymorphism. ( 28364573 )
2017
37
Treatment of experimental periodontal disease by laser therapy in simvastatin-modified rats. ( 28877277 )
2017
38
Periodontal profile and radiographic characterization of the jaws in a patient with autosomal dominant osteopetrosis. ( 28469925 )
2017
39
Evaluation of Bacteriological Profile in the Apical Root Segment of the Patients with Primary Apical Periodontitis. ( 28050984 )
2017
40
Association between interleukin-8 levels and chronic periodontal disease: A PRISMA-compliant systematic review and meta-analysis. ( 28562542 )
2017
41
IL-6 and IL-10 gene polymorphisms in patients with aggressive periodontitis: effects on GCF, serum and clinic parameters. ( 28099578 )
2017
42
Receiver Operating Characteristic (ROC) Curve-based Prediction Model for Periodontal Disease Updated With the Calibrated Community Periodontal Index. ( 28753099 )
2017
43
Salivary Neuropeptides, Stress and Periodontitis. ( 28914594 )
2017
44
Matrix metalloproteinase-8 levels in periodontal disease patients: A systematic review. ( 28898418 )
2017
45
Role of herpesviruses in chronic periodontitis and their association with clinical parameters and in increasing severity of the disease. ( 28932137 )
2017
46
Transcriptome of Healthy Gingival Tissue from Edentulous Sites in Patients with a History of Aggressive Periodontitis. ( 28844188 )
2017
47
Association between IL-4 and IL-4R Polymorphisms and Periodontitis: A Meta-Analysis. ( 28392616 )
2017
48
Commentary on Baghaie et al. (2017): Out of the shadows, into the limelight-sobering salience of meta-analysis of chronic periodontitis in drug addiction. ( 28378333 )
2017
49
Association of periodontal disease with glycemic control in patients with type 2 diabetes in Indian population. ( 28050765 )
2017
50
Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease. ( 28929053 )
2017

Variations for Periodontitis

Expression for Periodontitis

Search GEO for disease gene expression data for Periodontitis.

Pathways for Periodontitis

GO Terms for Periodontitis

Sources for Periodontitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....